Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesExtending treatment after liver transplant may benefit patients with hepatitis C recurrence
EurekAlert, 11/02/09
Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood. The study looked at 241 consecutive liver transplant patients from 1999–2006. Patients were offered treatment if they tested positive hepatitis C, had recurrent hepatitis C with at least Stage I fibrosis on biopsy, and stable immunosuppression for a minimum of three months. Patients received either non–pegylated interferon tiw or pegylated interferon weekly in combination with ribavirin.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Imaging cuts in Medicare fee schedule: An access catastrophe and danger to patients
EurekAlert, 11/03/09
Even Low Alcohol Consumption Has A Negative Impact On Overall Health, Researchers Argue
ScienceDaily, 10/26/09
Be Overweight And Live Longer, German Study Suggests
ScienceDaily, 10/19/09
Sponsor
Article Search
Sponsor